Detalhe da pesquisa
1.
Lymphopenia in Esophageal Squamous Cell Carcinoma: Relationship to Malnutrition, Various Disease Parameters, and Response to Concurrent Chemoradiotherapy.
Oncologist
; 24(8): e677-e686, 2019 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-31040254
2.
Systemic immune-inflammation index predicting chemoradiation resistance and poor outcome in patients with stage III non-small cell lung cancer.
J Transl Med
; 15(1): 221, 2017 10 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-29089030
3.
High expression of long non-coding RNA AFAP1-AS1 predicts chemoradioresistance and poor prognosis in patients with esophageal squamous cell carcinoma treated with definitive chemoradiotherapy.
Mol Carcinog
; 55(12): 2095-2105, 2016 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-26756568
4.
Identification of the long non-coding RNA POU3F3 in plasma as a novel biomarker for diagnosis of esophageal squamous cell carcinoma.
Mol Cancer
; 14: 3, 2015 Jan 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-25608466
5.
Association of decreased expression of long non-coding RNA LOC285194 with chemoradiotherapy resistance and poor prognosis in esophageal squamous cell carcinoma.
J Transl Med
; 12: 233, 2014 Aug 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-25169763
6.
Concurrent chemoradiotherapy with S-1 compared with concurrent chemoradiotherapy with docetaxel and cisplatin for locally advanced esophageal squamous cell carcinoma.
Radiat Oncol
; 16(1): 94, 2021 May 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-34039375
7.
Association of Sarcopenia With Toxicity and Survival in Postoperative Recurrent Esophageal Squamous Cell Carcinoma Patients Receiving Chemoradiotherapy.
Front Oncol
; 11: 655071, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34307131
8.
Combination of long noncoding RNA MALAT1 and carcinoembryonic antigen for the diagnosis of malignant pleural effusion caused by lung cancer.
Onco Targets Ther
; 11: 2333-2344, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-29731641
9.
Neutrophil-to-lymphocyte ratio as a prognostic biomarker for patients with locally advanced esophageal squamous cell carcinoma treated with definitive chemoradiotherapy.
Sci Rep
; 7: 42581, 2017 02 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-28195186
10.
Comparison of efficacy for postoperative chemotherapy and concurrent radiochemotherapy in patients with IIIA-pN2 non-small cell lung cancer: an early closed randomized controlled trial.
Radiother Oncol
; 110(1): 120-5, 2014 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-24183868
11.
[A randomized controlled trial of intensity-modulated radiation therapy plus docetaxel and cisplatin versus simple intensity-modulated radiation therapy in II-III stage esophageal carcinoma].
Zhonghua Wei Chang Wai Ke Za Zhi
; 16(9): 842-5, 2013 Sep.
Artigo
em Zh
| MEDLINE | ID: mdl-24061990
12.
A randomized controlled study of single-agent cisplatin and radiotherapy versus docetaxel/cisplatin and radiotherapy in high-risk early-stage cervical cancer after radical surgery.
J Cancer Res Clin Oncol
; 139(4): 703-8, 2013 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-23328996
13.
A randomized, controlled, multicenter study comparing intensity-modulated radiotherapy plus concurrent chemotherapy with chemotherapy alone in gastric cancer patients with D2 resection.
Radiother Oncol
; 104(3): 361-6, 2012 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-22985776
14.
[Feasibility and short-term efficacy of simplified intensity-modulated radiotherapy and concurrent chemotherapy for neck and upper thoracic esophageal carcinoma].
Ai Zheng
; 28(12): 1265-9, 2009 Dec.
Artigo
em Zh
| MEDLINE | ID: mdl-19958620